Novel Drug Therapies in General Health Care: A Review of Efficacy and Safety

Abstract

By enhancing patient outcomes, lowering side effects, and improving disease management, novel pharmacological therapies have revolutionized general healthcare. Innovative treatments such biologics, monoclonal antibodies, gene therapies, and drugs based on nanomedicine have been developed as a result of advances in biotechnology, pharmacogenomics, and targeted drug delivery systems. Although these therapies are more effective than traditional treatments, there are still issues with accessibility, cost, and safety. The findings suggest that while novel therapies significantly improve disease prognosis, careful monitoring and regulatory evaluation are essential to ensure patient safety.